Literature DB >> 16133515

Usefulness of endoscopic marking for determining the location of transanal endorectal pull-through in the treatment of Hirschsprung's disease.

Miyuki Kohno1, Hiromichi Ikawa, Hironori Fukumoto, Shinya Okamoto, Hiroaki Masuyama, Kunio Konuma.   

Abstract

In the treatment of Hirschsprung's disease, transanal endorectal pull-through (TEPT) is being performed without laparoscopic assistance or laparotomy for short-segment aganglionosis. Preoperative ascertainment of the extent of aganglionosis is required, as this affects the planning for TEPT. The present study investigated the usefulness of preoperative endoscopic marking as an intraoperative marker of the location of pull-through. Since 1998, we have performed TEPT using a prolapsing technique for the treatment of Hirschsprung's disease. Subjects comprised 17 patients with short-segment aganglionosis and 2 patients with long-segment aganglionosis in whom endoscopic marking was performed preoperatively. Median age at time of surgery was 2.7 months. The relationship between pathologic findings at the marked area and location of actual pull-through was investigated. For endoscopic marking, each patient was sedated using intravenous ketamine hydrochloride. The junction between normal bowel with peristalsis and aganglionic bowel without peristalsis ("shorebreak" finding) was marked by either tattooing or clipping. Normal ganglion cells were seen in the marked area of 14 patients, and pull-through was performed at the marked area in each of these patients. In three patients, ganglion cells existed in the marked area, but the number of ganglion cells was considered insufficient. Additional frozen sections were thus prepared to ascertain the area with normal ganglion cells, showing that normal ganglion cells were seen 1, 3 or 5 cm proximal to the marked area. In one patient, no ganglion cells were seen in the marked area, but were present 5 cm proximal to the marked area. In the remaining one patient, normal ganglion cells were seen 7 cm distal to the marked area. Pathologic findings revealed ganglion cells at the shorebreak finding in 17 of the 19 patients (89.5%), suggesting that this junction basically matches the distribution of ganglion cells. Endoscopic marking of the junction is very useful for determining the tip of pull-through.

Entities:  

Mesh:

Year:  2005        PMID: 16133515     DOI: 10.1007/s00383-005-1505-7

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  12 in total

1.  Endoscopic marking of colonic lesions.

Authors:  J L Ponsky; J F King
Journal:  Gastrointest Endosc       Date:  1975-08       Impact factor: 9.427

2.  Laparoscopy-assisted suction colonic biopsy and intraoperative rapid acetylcholinesterase staining during transanal pull-through for Hirschsprung's disease.

Authors:  Atsuyuki Yamataka; Ryuji Yoshida; Hiroyuki Kobayashi; Kanako Tsukamoto; Geoffrey J Lane; Osamu Segawa; Shingo Kameoka; Takeshi Miyano
Journal:  J Pediatr Surg       Date:  2002-12       Impact factor: 2.545

3.  The role of transanal endorectal pull-through in the treatment of Hirschsprung's disease - a multicenter experience.

Authors:  M E Höllwarth; M Rivosecchi; J Schleef; S Deluggi; G Fasching; E Ceriati; G Ciprandi; F DePeppo
Journal:  Pediatr Surg Int       Date:  2002-07-10       Impact factor: 1.827

4.  Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung's disease: Implications for surgical approach.

Authors:  M L Proctor; J Traubici; J C Langer; D L Gibbs; S H Ein; A Daneman; P C W Kim
Journal:  J Pediatr Surg       Date:  2003-05       Impact factor: 2.545

5.  Extra-anal mucosectomy: laparascopic-assisted endorectal pull-through using a prolapsing technique.

Authors:  Y Morikawa; K Hoshino; K Matsumura; S Yoshioka; J Yokoyama; M Kitajima
Journal:  J Pediatr Surg       Date:  1998-11       Impact factor: 2.545

6.  Perineal one-stage pull-through for Hirschsprung's disease.

Authors:  C T Albanese; R W Jennings; B Smith; B Bratton; M R Harrison
Journal:  J Pediatr Surg       Date:  1999-03       Impact factor: 2.545

7.  A new endoscopic tattooing technique for identifying the location of colonic lesions during laparoscopic surgery: a comparison with the conventional technique.

Authors:  K I Fu; T Fujii; S Kato; Y Sano; I Koba; K Mera; H Saito; T Yoshino; M Sugito; S Yoshida
Journal:  Endoscopy       Date:  2001-08       Impact factor: 10.093

8.  Transanal one-stage Soave procedure for infants with Hirschsprung's disease.

Authors:  J C Langer; R K Minkes; M V Mazziotti; M A Skinner; A L Winthrop
Journal:  J Pediatr Surg       Date:  1999-01       Impact factor: 2.545

9.  Does the transition zone reliably delineate aganglionic bowel in Hirschsprung's disease?

Authors:  Douglas H Jamieson; Simone E Dundas; Shaika Al Belushi; Moira Cooper; Geoffrey K Blair
Journal:  Pediatr Radiol       Date:  2004-07-27

10.  One-stage transanal Soave pullthrough for Hirschsprung disease: a multicenter experience with 141 children.

Authors:  Jacob C Langer; Audrey C Durrant; Luis de la Torre; Daniel H Teitelbaum; Robert K Minkes; Michael G Caty; Barbara E Wildhaber; S Jose Ortega; Shinjiro Hirose; Craig T Albanese
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

View more
  2 in total

1.  Application of a plain abdominal radiograph transition zone (PARTZ) in Hirschsprung's disease.

Authors:  Akshay Pratap; Devendra K Gupta; Awadhesh Tiwari; Arvind K Sinha; Nisha Bhatta; Satyendra N Singh; Chandra S Agrawal; Anand Kumar; Shailesh Adhikary
Journal:  BMC Pediatr       Date:  2007-01-27       Impact factor: 2.125

2.  Hematemesis With Gastric Laceration After Tattooing a Polyp With Purified Carbon: A Review of the Literature.

Authors:  Ana Isabel Gonzalez-Tallon; Miguel Rivero-Fernandez; Irina Calvo-Ramos; Antonio Diaz-Sanchez; Maria Del Rosario Gonzalez-Alonso; Elsa De la Fuente-Briongos; Rebeba Manzano-Fernandez; Eloisa Moya-Valverde; Jose Maria Riesco-Lopez; Rocio Campos-Cantero
Journal:  Gastroenterology Res       Date:  2017-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.